Impact of COPD on pulmonary survival of patients under complications and on long-term going surgery for NSCLC

被引:133
作者
Sekine, Y
Behnia, M
Fujisawa, T
机构
[1] Chiba Univ, Grad Sch Med, Dept Thorac Surg, YS TF,Chuo Ku, Chiba 2608670, Japan
[2] Indiana Univ, Sch Med, Dept Med, Div Pulm Allergy Crit Care & Occupat Med,YS MB, Indianapolis, IN USA
关键词
pulmonary resection; COPD; non-small cell lung cancer; postoperative complication; long-term survival; multivariate analysis;
D O I
10.1016/S0169-5002(02)00014-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The Purpose of our study was to determine the incidence of various types of postoperative pulmonary complications and to evaluate the impact of chronic obstructive pulmonary disease (COPD) on the long-term survival of patients with non-small cell lung cancer (NSCLC) undergoing pulmonary resection, Jfethodv.- We performed a retrospective chart review of 244 patients who had undergone lung resection for NSCLC at Indiana University. COPD, defined as predicted forced expiratory volume in 1 s (FEV1) less than or equal to 70% and FEV1/FVC less than or equal to 70%, was determined based on preoperative pulmonary function testing in 78 of 244 patients (COPD group). The remaining 166 patients were classified as non-COPD. The incidence of post operative complications, which included air leak of greater than or equal to 10 days. atelectasis, pneumothorax, pneumonia, bronchopleural fistula, empyema, acute respiratory distress syndrome, mechanical ventilation of greater than or equal to7 days, and outpatient oxygen supplementation were compared between the two groups. Long-term survival and mortality due to respiratory failure were analyzed between the two groups using the Kaplan-Meier method and log rank test. Results: All of the above-stated postoperative pulmonary complications occurred more frequently in the COPD than in the non-COPD patients (all P < 0.01). The overall 5-year survival rate was 36.2% in the COPD and 41.2% in the non-COPD patients (P = 0.1013). Five-year cancer related survival was 43.2% in the COPD and 47.7% in the non-COPD patients (P = 0.357). There was no significant difference in Survival among patients with different stages of lung cancer, However, the intercurrent survival, which is associated with non-cancer related death, was 60.1%, in patients with COPD and 86.2%. in patients without COPD at 5 years (P < 0.0001). The major cause of non-cancer related death in the COPD group was respiratory failure (P = 0.0008). Conclusion: The presence of COPD is an acceptable predictor of postoperative pulmonary complications in patients with NSCLC. COPD is also a significant risk factor for development of respiratory-related complications, which may explain the poor long-term survival in these patients. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 34 条
[1]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[2]   ASSESSMENT OF EXERCISE OXYGEN-CONSUMPTION AS PREOPERATIVE CRITERION FOR LUNG RESECTION [J].
BECHARD, D ;
WETSTEIN, L .
ANNALS OF THORACIC SURGERY, 1987, 44 (04) :344-349
[3]  
BUIST AS, 1994, TXB RESP MED, P1259
[4]  
BUSH E, 1994, CHEST, V105, P760
[5]  
Dautzenberg B, 1999, CANCER-AM CANCER SOC, V86, P265, DOI 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO
[6]  
2-B
[7]   EVALUATION OF RISK IN PULMONARY RESECTION FOR BRONCHOGENIC CARCINOMA [J].
DIDOLKAR, MS ;
MOORE, RH ;
TAKITA, H .
AMERICAN JOURNAL OF SURGERY, 1974, 127 (06) :700-703
[8]   Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas [J].
Fujisawa, T ;
Iizasa, T ;
Saitoh, Y ;
Sekine, Y ;
Motohashi, S ;
Yasukawa, T ;
Shibuya, K ;
Hiroshima, K ;
Ohwada, H .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2086-2091
[9]  
GAENSLER EA, 1955, J THORAC SURG, V29, P163
[10]  
GAIL MH, 1984, CANCER, V54, P1802, DOI 10.1002/1097-0142(19841101)54:9<1802::AID-CNCR2820540908>3.0.CO